Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: January 25, 2022
Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery (MINA)
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 120
  • Start Date: January 1, 2022
Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation (ICM REDUCE-AF)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Diagnostic Test
  • Participants: 1368
  • Start Date: January 1, 2022
D-Dimer-based Indication for Transesophageal Echocardiography to Exclude Left Atrial Thrombus Before Cardioversion of Non-anticoagulated Atrial Fibrillation: A Multicenter Belgian Study
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 2000
  • Start Date: January 2022
INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Procedure
  • Participants: 30
  • Start Date: November 30, 2021
Safety and Feasibility of Atrial Deganglionation as Adjunctive Therapy for Atrial Fibrillation
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 100
  • Start Date: October 2021
Semaglutide for the Reduction of Arrhythmia Burden in Overweight and Obese Patients With Atrial Fibrillation (Pilot Study)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 6090
  • Start Date: October 1, 2021
Effectiveness of Echocardiographic Screening of Pregnant Women During Antenatal Care: a Cluster Randomized Crossover Trial
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Device, Other
  • Participants: 477
  • Start Date: October 1, 2021
Confirm Rx Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High Risk Heart Failure Patients
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 590
  • Start Date: October 1, 2021
AntiCoagulation Tracking InterVention and Evaluation: Using a Customized Panel Management Platform to Improve Outcomes for Patients on Anticoagulation
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Procedure
  • Participants: 50
  • Start Date: September 20, 2021
Outcomes of High Power Application in Catheter Ablation of Paroxysmal Atrial Fibrillation Guided by Unipolar Signal Modification.
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Device, Procedure
  • Participants: 77
  • Start Date: September 1, 2021
Personalized Atrial Fibrillation Ablation With the QDOT Catheter - The QDOT-by-LAW Trial
Showing 1-12 of 929